https://www.businesswire.com/news/home/20200205005092/en/JenaValve-Technology-Closes-50-Million-Financing
they are doing a great job getting financing for their TAVR. Their CEO has being in medtech for long time. Just wondering if likes of Credit Suisse would prefer having a veteran valve leader from likes of Edwards/Medtronic at helm, feel would given more credability and sit well with the medical advisor network that the company has now setup . Would give me confidence as investor in company who has being in this business longer then a couple of years in the trade.
New AVR detailed research report with valuations, page-89
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.48 |
Change
-0.520(3.71%) |
Mkt cap ! $294.2M | |||
| Open | High | Low | Value | Volume |
| $14.20 | $14.41 | $13.30 | $107.4K | 7.859K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 17 | $13.27 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.47 | 326 | 2 |
View Market Depth
| Last trade - 14.31pm 28/08/2024 (20 minute delay) ? |
| AVR (ASX) Chart |